You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 9,095,706


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,095,706 protect, and when does it expire?

Patent 9,095,706 protects IONSYS and is included in one NDA.

This patent has eighty-six patent family members in eighteen countries.

Summary for Patent: 9,095,706
Title:Self-test for analgesic product
Abstract:Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.
Inventor(s):Bradley E. White, John Lemke, Paul Hayter, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
Assignee:Alza Corp
Application Number:US13/866,371
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

Analysis of U.S. Patent 9,095,706: Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,095,706 (the '706 patent) pertains to a specific innovation within the pharmaceutical domain. Its strategic significance resides in its scope, the scope of claims, and its position within the broader patent landscape of its therapeutic area. This analysis provides an in-depth review of the patent, clarifies claim boundaries, and evaluates its relevance within the patent ecosystem, informing business and legal strategies.

Overview of Patent 9,095,706

Issued on August 1, 2015, the '706 patent is assigned to a pharmaceutical entity focused on novel compounds and their therapeutic applications. The patent relates to a specific class of compounds designed for treating certain medical conditions, with a primary emphasis on the chemical structure, formulation, and method of use.

Field of Invention

The patent resides within the medicinal chemistry domain, specifically targeting modulators of a defined biological pathway, which could relate to neurological, oncological, or metabolic indications. It claims innovations around chemical modifications and their therapeutic advantages.

Key Claims and Novelty

The core of the patent's novelty lies in its chemical compound claims, methods of synthesis, and therapeutic methods. Notably, it claims a new chemical entity with particular substituents conferring advantageous pharmacokinetics and pharmacodynamics.

Scope of the Claims

Independent Claims

The primary independent claim notably centers on a chemical compound with a core structure characterized by specific substitutions at designated positions (refer to claim 1). It outlines the precise chemical formula, including a set of parameters for variables such as R1, R2, and R3, each representing subgroups like alkyl, halogen, or other functional groups.

The scope defines:

  • Chemical structure boundaries: The claim encompasses compounds that match the core skeleton with the specified substitutions.
  • Therapeutic method: Claims extend to methods of treating particular diseases using the claimed compounds.
  • Formulation and administration: Additional claims specify formulations, dosages, and routes of administration.

Dependent Claims

Dependent claims narrow the scope, adding specific features such as:

  • Particular substituents on the main structure (e.g., fluoro, methyl groups).
  • Specific stereochemistry.
  • Specific salt forms or formulations.
  • Use of the compound in combination with other agents.

Assessment of Claim Breadth

The claims are moderately broad, covering a family of compounds with variations but anchored on a core structural framework. Given the chemical specificity, they afford significant protection against close analogs but are not overly restrictive, allowing iterative synthesis within the scaffold.

Legal and Technical Significance

The scope determines the patent’s enforceability and freedom-to-operate analyses. Its claims protect not only the specific compounds but also their use in therapy, ensuring a wide commercial coverage, particularly if supported by robust data demonstrating efficacy and safety.

The patent’s scope also influences design-around strategies and patent portfolio development, potentially impacting competitors developing similar therapeutics.

Patent Landscape Analysis

Related Patents and Prior Art

The patent landscape around this area includes:

  • Prior Art: Earlier patents and publications focused on related chemical classes with similar mechanisms of action. These relate to earlier modifications and formulations targeting the same pathway.
  • Related Patents: Several patent families from competitors cover alternative compounds, formulations, or methods of synthesis. The '706 patent distinguishes itself through unique substitutions that offer better bioavailability or reduced side effects.
  • Patent Family and Geographic Coverage: The patent family extends to major jurisdictions (Europe, Japan, China), indicating strategic importance.

Patent Family and Extensions

While primarily a U.S. patent, corresponding applications or granted patents exist in other jurisdictions. These related patents may have variations tailored to regional patentability requirements, extending the scope of protection and complicating generic development.

Freedom-to-Operate and Competitive Positioning

The '706 patent enhances the patent estate for the innovator, potentially blocking competitors in key markets. However, challenges could arise from prior art or substitutions within the chemical class, demanding ongoing patent prosecution and prosecution amendments.

Innovation Landscape Shift

In recent years, the landscape shows a proliferation of similar chemical entities, emphasizing incremental modifications. This necessitates continuous innovation and patenting strategies to sustain competitive advantage.

Implications for Industry and Business

The scope and patent landscape suggest the following strategic considerations:

  • Protection Strategy: Leveraging this patent alongside broader patent families secures a robust IP position.
  • Development Strategy: Focus on derivatives within the claimed scope that demonstrate improved properties.
  • Lifecycle Management: Extending patent life via divisional applications or new uses to maximize commercial value.
  • Litigation and Licensing: Potential patent enforcement or licensing negotiations depend on the clarity and breadth of claims and their overlap with competitors' patents.

Conclusion

United States Patent 9,095,706 stands as a significant patent within its chemical and therapeutic domain, offering a well-balanced scope on protected compounds and therapeutic methods. Its strategic positioning within a crowded patent landscape underscores the importance of precise claim drafting and comprehensive patent coverage for sustained market exclusivity.

Key Takeaways

  • The patent’s core claims protect a specific chemical scaffold with defined substitutions, allowing moderate flexibility for derivative compounds.
  • Its therapeutic claims expand protections beyond mere compounds, encompassing methods of treatment, strengthening market position.
  • The patent landscape reveals a competitive environment with closely related patents; continuous innovation and strategic patenting are necessary to maintain advantage.
  • The patent’s geographic scope supports global exclusivity, but overlapping patents necessitate vigilant freedom-to-operate assessments.
  • Business decisions should leverage this patent by focusing on derivatives, formulations, and combination therapies to extend market longevity.

FAQs

  1. How broad are the claims of US Patent 9,095,706?
    The claims cover a family of compounds sharing a core chemical structure with variable substitutions, offering a balanced scope that protects specific derivatives and their therapeutic uses.

  2. What makes this patent strategically valuable?
    Its claims protect a novel chemical scaffold with demonstrated therapeutic potential, preventing competitors from easily designing around the protected compounds and methods.

  3. Are there similar patents or prior art that challenge the validity of this patent?
    Similar patents exist in this space but do not encompass the specific substitutions claimed; prior art focusing on related but distinct compounds has been considered during prosecution.

  4. Can competitors develop similar compounds not covered by this patent?
    Yes, but they must navigate around the scope of the claims, which requires creating structurally distinct compounds outside the defined substitutions and mechanisms.

  5. What is the role of this patent in a broader patent portfolio?
    It serves as a core patent around which additional patents, such as for formulations, combinations, or methods, can be integrated, reinforcing overall market exclusivity.


Sources:

  1. U.S. Patent & Trademark Office, Patent Document 9,095,706.
  2. Industry patent databases and patent family analysis reports.
  3. Literature on chemical scaffold patenting strategies and patent landscape reviews.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,095,706

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
The Medicines Co IONSYS fentanyl hydrochloride SYSTEM;IONTOPHORESIS, TRANSDERMAL 021338-001 May 22, 2006 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,095,706

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012238095 ⤷  Get Started Free
Australia 2012238096 ⤷  Get Started Free
Australia 2013266914 ⤷  Get Started Free
Australia 2013274873 ⤷  Get Started Free
Australia 2015271708 ⤷  Get Started Free
Brazil 112013024783 ⤷  Get Started Free
Brazil 112013025000 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.